Related Experiment Video
Updated: Aug 14, 2026
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm
Elisabetta Ferretti1, Enrico De Smaele, Lucia Di Marcotullio
1Department of Experimental Medicine and Pathology, La Sapienza University, Viale Regina Elena 324, 00161 Rome, Italy.
Abstract:
Medulloblastomas often activate Hedgehog signaling inappropriately. The finding that mutations in components of this pathway are present only in few tumors suggests that additional genetic or epigenetic lesions can also lead to Hedgehog dysregulation. Chromosome 17p deletion, the most frequently detected genetic lesion in medulloblastoma, has recently been identified as a cause of unrestrained Hedgehog signaling. Such a deletion leads to the loss of REN(KCTD11), a novel Hedgehog antagonist, thus removing a checkpoint of Hedgehog-dependent events during cerebellum development and tumorigenesis. The disruption of additional Hedgehog modulators that map to 17p suggests a rationale for a multitargeted therapeutic strategy aimed at interrupting the cooperative activation of the Hedgehog pathway.
Insights
Medulloblastoma frequently involves abnormal Hedgehog signaling. Chromosome 17p deletion causes this by removing REN, a Hedgehog antagonist, impacting cerebellum development and tumor growth.
Area of Science:
- Oncology
- Developmental Biology
- Genetics
Background:
- Medulloblastomas often exhibit aberrant Hedgehog signaling, crucial for development.
- While pathway mutations are infrequent, other genetic or epigenetic factors likely contribute to dysregulation.
- Chromosome 17p deletion is the most common genetic alteration in medulloblastoma.
Purpose of the Study:
- To investigate the role of chromosome 17p deletion in medulloblastoma Hedgehog pathway activation.
- To identify the specific mechanisms by which 17p deletion leads to Hedgehog signaling dysregulation.
- To explore potential therapeutic strategies targeting Hedgehog pathway cooperativity.
Main Methods:
- Analysis of genetic lesions in medulloblastoma samples.
- Investigation of Hedgehog pathway components and their regulation.
- Functional studies on the role of REN (KCTD11) in development and tumorigenesis.
Main Results:
- Chromosome 17p deletion was identified as a cause of unrestrained Hedgehog signaling in medulloblastoma.
- This deletion leads to the loss of REN (KCTD11), a novel Hedgehog antagonist.
- Disruption of other Hedgehog modulators on chromosome 17p was observed.
Conclusions:
- Loss of REN due to 17p deletion removes a critical checkpoint for Hedgehog signaling during cerebellum development and medulloblastoma formation.
- The findings support a multitargeted therapeutic approach for medulloblastoma by interrupting cooperative Hedgehog pathway activation.
Related Concept Videos
02:33Hedgehog Signaling Pathway
02:33Hedgehog Signaling Pathway
02:23Abnormal Proliferation
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:23Negative Regulator Molecules